These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7271272)

  • 1. Pharmacokinetics of netilmicin in children with and without cystic fibrosis.
    Michalsen H; Bergan T
    Antimicrob Agents Chemother; 1981 Jun; 19(6):1029-31. PubMed ID: 7271272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic assessment of netilmicin in newborns and older children.
    Bergan T; Michalsen H
    Infection; 1982; 10(3):153-8. PubMed ID: 7107013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicted tissue accumulation of netilmicin in patients.
    Edwards DJ; Mangione A; Cumbo TJ; Schentag JJ
    Antimicrob Agents Chemother; 1981 Dec; 20(6):714-7. PubMed ID: 7325637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and dosage requirements of netilmicin in cystic fibrosis patients.
    Bosso JA; Townsend PL; Herbst JJ; Matsen JM
    Antimicrob Agents Chemother; 1985 Dec; 28(6):829-31. PubMed ID: 4083865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of netilmicin in patients with renal impairment and in patients on dialysis.
    Luft FC; Brannon DR; Stropes LL; Costello RJ; Sloan RS; Maxwell DR
    Antimicrob Agents Chemother; 1978 Sep; 14(3):403-7. PubMed ID: 708018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition of tobramycin in patients with cystic fibrosis: a prospective controlled study.
    Levy J; Smith AL; Koup JR; Williams-Warren J; Ramsey B
    J Pediatr; 1984 Jul; 105(1):117-24. PubMed ID: 6376743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of netilmicin in renal insufficiency and haemodialysis.
    Pechere JC; Dugal R; Pechere MM
    Clin Pharmacokinet; 1978; 3(5):395-406. PubMed ID: 699461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of netilmicin and gentamicin pharmacokinetics in humans.
    Chung M; Costello R; Symchowicz S
    Antimicrob Agents Chemother; 1980 Feb; 17(2):184-7. PubMed ID: 7387140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicompartment pharmacokinetics of netilmicin.
    Wenk M; Spring P; Vozeh S; Follath F
    Eur J Clin Pharmacol; 1979 Nov; 16(5):331-4. PubMed ID: 520400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic properties of netilmicin in newborn infants.
    Siegel JD; McCracken GH; Thomas ML; Threlkeld N
    Antimicrob Agents Chemother; 1979 Feb; 15(2):246-53. PubMed ID: 426516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical use of a one-compartment model for determining netilmicin pharmacokinetic parameters and dosage recommendations.
    Rotschafer JC; Crossley KB; Zaske DE; Russillo NJ; Strate RG; Tofte RW; Solem LD
    Ther Drug Monit; 1983; 5(3):263-7. PubMed ID: 6636253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pharmacokinetics of aminoglycoside antibiotics in guinea pigs.
    Chung M; Parravicini L; Assael BM; Cavanna G; Radwanski E; Symchowicz S
    Antimicrob Agents Chemother; 1982 Dec; 22(6):1017-21. PubMed ID: 7159067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of dibekacin in children with cystic fibrosis.
    Courcol RJ; Loeuille GA; Delnatte J; Martin GR
    Int J Clin Pharmacol Res; 1985; 5(2):87-91. PubMed ID: 4018945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of aztreonam in healthy subjects and patients with cystic fibrosis and evaluation of dose-exposure relationships using monte carlo simulation.
    Vinks AA; van Rossem RN; Mathôt RA; Heijerman HG; Mouton JW
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3049-55. PubMed ID: 17576827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased dosage requirements of tobramycin and gentamicin for treating Pseudomonas pneumonia in patients with cystic fibrosis.
    Mann HJ; Canafax DM; Cipolle RJ; Daniels CE; Zaske DE; Warwick WJ
    Pediatr Pulmonol; 1985; 1(5):238-43. PubMed ID: 4069813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of netilmicin in premature infants.
    Kuhn RJ; Nahata MC; Powell DA; Bickers RG
    Eur J Clin Pharmacol; 1986; 29(5):635-7. PubMed ID: 3956569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probenecid pharmacokinetics in cystic fibrosis.
    Weber A; de Groot R; Ramsey B; Williams-Warren J; Smith A
    Dev Pharmacol Ther; 1991; 16(1):7-12. PubMed ID: 1879255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of netilmicin in the presence of normal or impaired renal function.
    Humbert G; Leroy A; Fillastre JP; Oksenhendler G
    Antimicrob Agents Chemother; 1978 Jul; 14(1):40-4. PubMed ID: 686708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of ciprofloxacin in cystic fibrosis.
    Davis RL; Koup JR; Williams-Warren J; Weber A; Heggen L; Stempel D; Smith AL
    Antimicrob Agents Chemother; 1987 Jun; 31(6):915-9. PubMed ID: 3619423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosing implications of altered gentamicin disposition in patients with cystic fibrosis.
    Kearns GL; Hilman BC; Wilson JT
    J Pediatr; 1982 Feb; 100(2):312-8. PubMed ID: 7035640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.